Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar
Final Published scheduled for 12 (4)

Zolpidem-Induced Acute Altered Level of Consciousness: A Report of Two Cases

Abdolhamid Parsa 1 , Seyyed Ali Tabaeian 2 , Sadra Einizadeh 3 and Mohammad Babaeian 1 , *
Authors Information
1 School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3 School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: December 2018, In Press (In Press); e9979
  • Published Online: September 15, 2018
  • Article Type: Case Report
  • Received: December 9, 2016
  • Revised: July 9, 2017
  • Accepted: October 2, 2017
  • DOI: 10.5812/ijpbs.9979

To Cite: Parsa A, Tabaeian S A, Einizadeh S, Babaeian M. Zolpidem-Induced Acute Altered Level of Consciousness: A Report of Two Cases, Iran J Psychiatry Behav Sci. 2018 ; In Press(In Press):e9979. doi: 10.5812/ijpbs.9979.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Langtry HD, Benfield P. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs. 1990;40(2):291-313. doi: 10.2165/00003495-199040020-00008. [PubMed: 2226217].
  • 2. Ganzoni E, Santoni JP, Chevillard V, Sebille M, Mathy B. Zolpidem in insomnia: A 3-year post-marketing surveillance study in Switzerland. J Int Med Res. 1995;23(1):61-73. doi: 10.1177/030006059502300108. [PubMed: 7774760].
  • 3. Kang DY, Park S, Rhee CW, Kim YJ, Choi NK, Lee J, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health. 2012;45(4):219-26. doi: 10.3961/jpmph.2012.45.4.219. [PubMed: 22880153]. [PubMed Central: PMC3412984].
  • 4. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001;49(12):1685-90. doi: 10.1111/j.1532-5415.2001.49280.x. [PubMed: 11844004].
  • 5. Hajak G, Bandelow B. Safety and tolerance of zolpidem in the treatment of disturbed sleep: A post-marketing surveillance of 16944 cases. Int Clin Psychopharmacol. 1998;13(4):157-67. doi: 10.1097/00004850-199807000-00002. [PubMed: 9727726].
  • 6. Inagaki T, Miyaoka T, Tsuji S, Inami Y, Nishida A, Horiguchi J. Adverse reactions to zolpidem: Case reports and a review of the literature. Prim Care Companion J Clin Psychiatry. 2010;12(6). doi: 10.4088/PCC.09r00849bro. [PubMed: 21494350]. [PubMed Central: PMC3067983].
  • 7. Garnier R, Guerault E, Muzard D, Azoyan P, Chaumet-Riffaud AE, Efthymiou ML. Acute zolpidem poisoning analysis of 344 cases. J Toxicol Clin Toxicol. 1994;32(4):391-404. doi: 10.3109/15563659409011040. [PubMed: 8057398].
  • 8. Darcourt G, Pringuey D, Salliere D, Lavoisy J. The safety and tolerability of zolpidem an update. J Psychopharmacol. 1999;13(1):81-93. doi: 10.1177/026988119901300109. [PubMed: 10221362].
  • 9. Swainston Harrison T, Keating GM. Zolpidem: A review of its use in the management of insomnia. CNS Drugs. 2005;19(1):65-89. [PubMed: 15651908].
  • 10. Cardinali DP, Golombek DA, Rosenstein RE, Brusco LI, Vigo DE. Assessing the efficacy of melatonin to curtail benzodiazepine/Z drug abuse. Pharmacol Res. 2016;109:12-23. doi: 10.1016/j.phrs.2015.08.016. [PubMed: 26438969].
  • 11. Keuroghlian AS, Barry AS, Weiss RD. Circadian dysregulation, zolpidem dependence, and withdrawal seizure in a resident physician performing shift work. Am J Addict. 2012;21(6):576-7. doi: 10.1111/j.1521-0391.2012.00273.x. [PubMed: 23082842]. [PubMed Central: PMC3744365].
  • 12. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005;66 Suppl 9:31-41. [PubMed: 16336040].
  • 13. Paradis CM, Siegel LA, Kleinman SB. Two cases of zolpidem-associated homicide. Prim Care Companion CNS Disord. 2012;14(4). doi: 10.4088/PCC.12br01363. [PubMed: 23251862]. [PubMed Central: PMC3505131].
  • 14. Mortaz Hejri S, Faizi M, Babaeian M. Zolpidem-induced suicide attempt: A case report. Daru. 2013;21(1):77. doi: 10.1186/2008-2231-21-77. [PubMed: 24359886]. [PubMed Central: PMC3878174].
  • 15. Hamad A, Sharma N. Acute zolpidem overdose leading to coma and respiratory failure. Intensive Care Med. 2001;27(7):1239. doi: 10.1007/s001340100972. [PubMed: 11534578].
  • 16. Behrouz R, Godoy DA, Azarpazhooh MR, Di Napoli M. Altered mental status in the neurocritical care unit. J Crit Care. 2015;30(6):1272-7. doi: 10.1016/j.jcrc.2015.07.021. [PubMed: 26315655].
  • 17. Shuaib W, Beatrice C, Abazid AG. Zolpidem overdose: A medical and ethical dilemma. Am J Ther. 2016;23(6):e1956-7. doi: 10.1097/MJT.0000000000000380. [PubMed: 26539907].
  • 18. Lehman RK, Mink J. Altered mental status. Clin Pediatr Emerg Med. 2008;9(2):68-75. doi: 10.1016/j.cpem.2008.02.003.
  • 19. Murty S. Altered mental status. In: David SS, editor. Clinical pathways in emergency medicine. Springer; 2016.
  • 20. World Health Organization. ICD-11 beta draft. 2015. Available from: http://apps.who.int/classifications/icd11/browse/l-m/en.
  • 21. Judd SJ. Sleepwalking. Sleep disorders sourcebook. Omnigraphics; 2010.
  • 22. Singhal S, Jain PC. Wireless health monitoring system for sleepwalking patients. 2015 39th National Systems Conference (NSC), IEEE; 2015. doi: 10.1109/natsys.2015.7489083.
  • 23. U.S. Food and Drug Administration (FDA). Risk of next‐morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist). 2014.
  • 24. Yaripour S, Nezami Rashid S, Alibakhshi H, Mohammadi A. Development and validation of a stability-indicating reversed phase HPLC method for the quality control of Zolpidem in bulk and tablet dosage forms. J Anal Chem. 2015;70(6):738-43. doi: 10.1134/s1061934815060143.
  • 25. Najjar M. Zolpidem and amnestic sleep related eating disorder. J Clin Sleep Med. 2007;3(6):637-8. [PubMed: 17993047]. [PubMed Central: PMC2045714].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments